Other studies have suggested that lysosomal biomass may be responsible for the resistance of other cancer types to CDK4/6 inhibition.[30] This may protect chemotherapy‐resistant SCLC cells during chemotherapeutic drug treatment. Here, CDK4 is linked to small cell lung carcinoma.